Your browser doesn't support javascript.
loading
Bisphosphonates and jaw osteonecrosis / Bisfosfonatos e osteonecrose dos maxilares
Maahs, Marcia Angelica Peter; Nora, Vanessa Paim; Azambuja, Alan Arrieira; Cherubini, Karen.
  • Maahs, Marcia Angelica Peter; Pontifical Catholic University of Rio Grande do Sul. Porto Alegre. BR
  • Nora, Vanessa Paim; Pontifical Catholic University of Rio Grande do Sul. Porto Alegre. BR
  • Azambuja, Alan Arrieira; Pontifical Catholic University of Rio Grande do Sul. Porto Alegre. BR
  • Cherubini, Karen; Pontifical Catholic University of Rio Grande do Sul. Porto Alegre. BR
Rev. odonto ciênc ; 24(4): 337-344, Oct.-Dec. 2009. ilus
Article in English | LILACS, BBO | ID: biblio-873984
ABSTRACT
Bisphosphonates have been widely prescribed for treatment of diseases characterized by intense bone resorption. These drugs have also been associated with a serious side effect, avascular osteonecrosis of the jaws. The authors present a literature review on bisphosphonates, focusing on their pharmacological features and their reported association with jaw osteonecrosis. The morbidity and lack of treatment response of this condition are serious facts to be considered when prescribing bisphosphonate therapy. The risk-benefit relationship needs to be seriously analyzed, and the treatment pros and cons should be explained to the patient. If the therapy with bisphosphonate is indicated, rigorous oral health adequacy must be performed and periodic evaluation of oral conditions is mandatory. At this moment, caution in treatment seems to be the best way to approach bisphosphonate users.
RESUMO
Os bisfosfonatos têm sido amplamente empregados no tratamento de enfermidades cuja característica principal é a intensa reabsorção óssea. Tais drogas também têm sido associadas a um importante efeito colateral - a osteonecrose avascular dos maxilares. Os autores apresentam uma revisão da literatura sobre bisfosfonatos, enfocando aspectos farmacológicos e a osteonecrose dos maxilares. A morbidade e a falta de resposta ao tratamento desta condição são fatores importantes a serem considerados na prescrição de terapia com bisfosfonatos. A relação risco-benefício precisa ser seriamente analisada, e os prós e contras do tratamento devem ser explicados ao paciente. Se a terapia for indicada, uma rigorosa adequação bucal deve ser realizada e o paciente necessita ser periodicamente avaliado. No presente momento, a precaução parece ser o melhor modo de abordar os usuários de bisfosfonatos.
Subject(s)

Full text: Available Index: LILACS (Americas) Main subject: Osteonecrosis / Mandible / Maxilla Language: English Journal: Rev. odonto ciênc Journal subject: Dentistry Year: 2009 Type: Article Affiliation country: Brazil Institution/Affiliation country: Pontifical Catholic University of Rio Grande do Sul/BR

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: Osteonecrosis / Mandible / Maxilla Language: English Journal: Rev. odonto ciênc Journal subject: Dentistry Year: 2009 Type: Article Affiliation country: Brazil Institution/Affiliation country: Pontifical Catholic University of Rio Grande do Sul/BR